OABI

OABI

USD

OmniAb Inc. Common Stock

$1.700-0.050 (-2.857%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.750

Máximo

$1.750

Mínimo

$1.690

Volumen

0.87M

Fundamentos de la Empresa

Capitalización de Mercado

214.1M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

1.12M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.22Actual $1.700Máximo $4.96

Noticias Relacionadas

BusinessWire

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three months ended March 31, 2025, and provided operating and partner program

Ver más
OmniAb Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

ZURICH, SWITZERLAND, May 5, 2025 -- VERAXA Biotech AG ("VERAXA"), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, "Voyager")),

Ver más
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
BusinessWire

OmniAb Announces Two New Appointments to its Board of Directors

Philip Gotwals, Ph.D. and Steve Crouse bring strategic and operational experience in business development and global tools and technology OmniAb, Inc. (NASDAQ:OABI) today announced the appointments of Philip J.

Ver más
OmniAb Announces Two New Appointments to its Board of Directors

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.